Lonza

Lonza, OncoMed to Collaborate on Anti-Cancer Therapeutics

Cobra Biologics Appoints John Birch Non-Executive Director

Lonza Says Demand Strong despite Headwinds

Lonza, Biowa Sign License Agreements with FivePrime Therapeutics

Lonza Announces Completion of New GMP Suite

Lonza, Agennix Sign Deal for Production of Talactoferrin

Lonza Appoints Richard Ridinger as New CEO

Stefan Borgas Fired as Lonza CEO

Topics • Chemistry

M&A in the Chemical Industry

Lonza Sees Growth on Pharma Outsourcing

Peter Pollak on the World of Fine Chemicals

Pharma Must Make Big Changes to Survive

Topics • Technology

Pharma’s Future with a Disaggregated Supply Chain

Lonza Obtains French Antitrust Clearance For Arch Chemicals Offer

Lonza To Build Formulation Plant in Visp

Arch Chemicals Q2 Profit Falls

Strong Franc hits Lonza's Profit

Lonza Begins Tender Offer To Acquire Arch Chemicals

Lonza to Buy Arch Chemicals for $1.2 Billion

Strong Swiss Franc Rise Threatens Competitiveness

Topics • Chemistry

Fine Chemicals: The Top 10

Lonza Expects Solid Growth in 2011, 2010 Net Up 79%

Lonza Shares Fall After Deutsche Bank Downgrade

Stefan Borgas: Strong Franc Major Challenge for Swiss Economy

Biosimilar Antibodies: EMA Adopts Guideline

Lonza Signs Manufacturing Deal with Glaxosmithkline

Lonza Acquires Viral Vaccine and Vector Manufacturer Vivante GMP Solutions

H1 2010: Lonza Reports Improved Order Placement and Contract Signing

Roche Maintains Focus as Industry Faces Cutbacks

Teva Tests Biosimilar Version of Roche's Rituxan

Topics • Technology

Cost, Quality And Reliability

Lonza Announces Cost-cutting Measures in Visp and Basel

Swiss Lonza Eyes Stake In India Drug Firm

Topics • Technology

Adapting For Survival

Lonza Streamlines Chemical Manufacturing Operations

1 more articles

Top-Feature

BIO Deutschland e.V.

German Biotech Days 2026: Biotechnology as The Key to Industrial Competitiveness

Global Impact Coalition (GIC)

Siemens Joins the Global Impact Coalition

CHEManager International c/o Wiley-VCH GmbH

Upcoming Virtual Events

Agilent Technologies Inc.

Comprehensive Insights into Antibody–Drug Conjugates (ADC) for Precision Cancer Therapy

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences

Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

Camelot Management Consultants AG

Mack Brooks Exhibition Ltd – Part of RX

DCAT - Drug, Chemical & Associated Technologies Association

Thomson Reuters

Global Gateway Advisors

Jan Ramakers Fine Chemical

Frost & Sullivan

PP Consulting

Pricewaterhouse Coopers

F. Hoffmann-La Roche Ltd

Microinnova Engineering GmbH

Scienceindustries - Wirtschaftsverband Chemie Pharma Life Sciences

Fraser Dove International

GETEC Group